ZA200505306B - Complexes of protein crystals and ionic polymers - Google Patents

Info

Publication number

ZA200505306B

ZA200505306B ZA200505306A ZA200505306A ZA200505306B ZA 200505306 B ZA200505306 B ZA 200505306B ZA 200505306 A ZA200505306 A ZA 200505306A ZA 200505306 A ZA200505306 A ZA 200505306A ZA 200505306 B ZA200505306 B ZA 200505306B

Authority

ZA

South Africa

Prior art keywords

protein

group

complex

composition

solution

Prior art date

2002-12-31

Links

• Espacenet
• Global Dossier
• Discuss

• 239000013078 crystal Substances 0.000 title claims description 208
• 102000004169 proteins and genes Human genes 0.000 title claims description 197
• 108090000623 proteins and genes Proteins 0.000 title claims description 197
• 229920000831 ionic polymer Polymers 0.000 title description 14
• 235000018102 proteins Nutrition 0.000 claims description 196
• 102000002265 Human Growth Hormone Human genes 0.000 claims description 128
• 108010000521 Human Growth Hormone Proteins 0.000 claims description 128
• 239000000854 Human Growth Hormone Substances 0.000 claims description 128
• 239000000203 mixture Substances 0.000 claims description 113
• 239000000243 solution Substances 0.000 claims description 96
• 238000002425 crystallisation Methods 0.000 claims description 66
• 230000008025 crystallization Effects 0.000 claims description 66
• 238000000034 method Methods 0.000 claims description 57
• 102000007327 Protamines Human genes 0.000 claims description 53
• 108010007568 Protamines Proteins 0.000 claims description 53
• -1 antibodies Proteins 0.000 claims description 49
• 150000008040 ionic compounds Chemical class 0.000 claims description 48
• 229920000724 poly(L-arginine) polymer Polymers 0.000 claims description 42
• 108010011110 polyarginine Proteins 0.000 claims description 42
• 239000000872 buffer Substances 0.000 claims description 34
• 229940048914 protamine Drugs 0.000 claims description 33
• 241000124008 Mammalia Species 0.000 claims description 29
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 29
• 108010084837 rasburicase Proteins 0.000 claims description 28
• 229960000424 rasburicase Drugs 0.000 claims description 28
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 25
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 25
• 229920000447 polyanionic polymer Polymers 0.000 claims description 24
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 24
• 239000000427 antigen Substances 0.000 claims description 23
• 108091007433 antigens Proteins 0.000 claims description 23
• 102000036639 antigens Human genes 0.000 claims description 23
• 229940088597 hormone Drugs 0.000 claims description 23
• 239000005556 hormone Substances 0.000 claims description 23
• 229920000642 polymer Polymers 0.000 claims description 23
• 239000000412 dendrimer Substances 0.000 claims description 21
• 229920000736 dendritic polymer Polymers 0.000 claims description 21
• 239000003153 chemical reaction reagent Substances 0.000 claims description 19
• 239000000122 growth hormone Substances 0.000 claims description 18
• 239000008367 deionised water Substances 0.000 claims description 17
• 229910021641 deionized water Inorganic materials 0.000 claims description 17
• 102000004190 Enzymes Human genes 0.000 claims description 16
• 108090000790 Enzymes Proteins 0.000 claims description 16
• 229940088598 enzyme Drugs 0.000 claims description 16
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
• 229920005862 polyol Polymers 0.000 claims description 15
• 150000003077 polyols Chemical class 0.000 claims description 15
• 108010008165 Etanercept Proteins 0.000 claims description 14
• 150000001413 amino acids Chemical class 0.000 claims description 14
• 229920001184 polypeptide Polymers 0.000 claims description 14
• 230000001225 therapeutic effect Effects 0.000 claims description 14
• 238000002347 injection Methods 0.000 claims description 13
• 239000007924 injection Substances 0.000 claims description 13
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
• 108010039918 Polylysine Proteins 0.000 claims description 12
• 210000000988 bone and bone Anatomy 0.000 claims description 12
• 230000000921 morphogenic effect Effects 0.000 claims description 12
• 229920000656 polylysine Polymers 0.000 claims description 12
• 239000003381 stabilizer Substances 0.000 claims description 12
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 11
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 11
• 239000007995 HEPES buffer Substances 0.000 claims description 11
• 239000003814 drug Substances 0.000 claims description 11
• 210000005036 nerve Anatomy 0.000 claims description 11
• 108010071942 Colony-Stimulating Factors Proteins 0.000 claims description 10
• 102000007644 Colony-Stimulating Factors Human genes 0.000 claims description 10
• 108090000854 Oxidoreductases Proteins 0.000 claims description 10
• 102000004316 Oxidoreductases Human genes 0.000 claims description 10
• 108010020346 Polyglutamic Acid Proteins 0.000 claims description 10
• 235000001014 amino acid Nutrition 0.000 claims description 10
• 229940047120 colony stimulating factors Drugs 0.000 claims description 10
• 239000003599 detergent Substances 0.000 claims description 10
• 238000002156 mixing Methods 0.000 claims description 10
• KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 claims description 10
• PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 claims description 10
• 229960000575 trastuzumab Drugs 0.000 claims description 10
• 102000003886 Glycoproteins Human genes 0.000 claims description 9
• 108090000288 Glycoproteins Proteins 0.000 claims description 9
• 102000004882 Lipase Human genes 0.000 claims description 9
• 108090001060 Lipase Proteins 0.000 claims description 9
• 239000004367 Lipase Substances 0.000 claims description 9
• 102000015636 Oligopeptides Human genes 0.000 claims description 9
• 108010038807 Oligopeptides Proteins 0.000 claims description 9
• 201000010099 disease Diseases 0.000 claims description 9
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
• 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 claims description 9
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 9
• 235000019421 lipase Nutrition 0.000 claims description 9
• 235000000346 sugar Nutrition 0.000 claims description 9
• 150000008163 sugars Chemical class 0.000 claims description 9
• 239000004382 Amylase Substances 0.000 claims description 8
• 102000013142 Amylases Human genes 0.000 claims description 8
• 108010065511 Amylases Proteins 0.000 claims description 8
• 108010002350 Interleukin-2 Proteins 0.000 claims description 8
• 102000000588 Interleukin-2 Human genes 0.000 claims description 8
• 108090001005 Interleukin-6 Proteins 0.000 claims description 8
• 108090001007 Interleukin-8 Proteins 0.000 claims description 8
• 235000019418 amylase Nutrition 0.000 claims description 8
• 239000003795 chemical substances by application Substances 0.000 claims description 8
• 238000004519 manufacturing process Methods 0.000 claims description 8
• 108010064470 polyaspartate Proteins 0.000 claims description 8
• 229960004641 rituximab Drugs 0.000 claims description 8
• 238000007920 subcutaneous administration Methods 0.000 claims description 8
• 108010054218 Factor VIII Proteins 0.000 claims description 7
• 102000001690 Factor VIII Human genes 0.000 claims description 7
• 108010002386 Interleukin-3 Proteins 0.000 claims description 7
• 108090000978 Interleukin-4 Proteins 0.000 claims description 7
• 108010002616 Interleukin-5 Proteins 0.000 claims description 7
• 108010002586 Interleukin-7 Proteins 0.000 claims description 7
• 108090000184 Selectins Proteins 0.000 claims description 7
• 102000003800 Selectins Human genes 0.000 claims description 7
• 229960000403 etanercept Drugs 0.000 claims description 7
• 229960000301 factor viii Drugs 0.000 claims description 7
• 108020001507 fusion proteins Proteins 0.000 claims description 7
• 102000037865 fusion proteins Human genes 0.000 claims description 7
• 239000003102 growth factor Substances 0.000 claims description 7
• 229920000136 polysorbate Polymers 0.000 claims description 7
• 235000004252 protein component Nutrition 0.000 claims description 7
• 102000004127 Cytokines Human genes 0.000 claims description 6
• 108090000695 Cytokines Proteins 0.000 claims description 6
• 229920002307 Dextran Polymers 0.000 claims description 6
• 102400000322 Glucagon-like peptide 1 Human genes 0.000 claims description 6
• DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 claims description 6
• 101800000224 Glucagon-like peptide 1 Proteins 0.000 claims description 6
• 102000036770 Islet Amyloid Polypeptide Human genes 0.000 claims description 6
• 108010041872 Islet Amyloid Polypeptide Proteins 0.000 claims description 6
• 102000004856 Lectins Human genes 0.000 claims description 6
• 108090001090 Lectins Proteins 0.000 claims description 6
• 102000008072 Lymphokines Human genes 0.000 claims description 6
• 108010074338 Lymphokines Proteins 0.000 claims description 6
• 108090000542 Lymphotoxin-alpha Proteins 0.000 claims description 6
• 102000004083 Lymphotoxin-alpha Human genes 0.000 claims description 6
• 102000014842 Multidrug resistance proteins Human genes 0.000 claims description 6
• 229920002472 Starch Polymers 0.000 claims description 6
• 108010091105 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 claims description 6
• 108010092464 Urate Oxidase Proteins 0.000 claims description 6
• 108010046334 Urease Proteins 0.000 claims description 6
• 235000010323 ascorbic acid Nutrition 0.000 claims description 6
• 239000011668 ascorbic acid Substances 0.000 claims description 6
• 239000001913 cellulose Substances 0.000 claims description 6
• 229920002678 cellulose Polymers 0.000 claims description 6
• 235000010980 cellulose Nutrition 0.000 claims description 6
• 210000003714 granulocyte Anatomy 0.000 claims description 6
• 239000003112 inhibitor Substances 0.000 claims description 6
• 230000005764 inhibitory process Effects 0.000 claims description 6
• 108010044426 integrins Proteins 0.000 claims description 6
• 102000006495 integrins Human genes 0.000 claims description 6
• 239000002523 lectin Substances 0.000 claims description 6
• 238000013508 migration Methods 0.000 claims description 6
• 230000005012 migration Effects 0.000 claims description 6
• 229920001983 poloxamer Polymers 0.000 claims description 6
• 229920000058 polyacrylate Polymers 0.000 claims description 6
• 229920001282 polysaccharide Polymers 0.000 claims description 6
• 239000005017 polysaccharide Substances 0.000 claims description 6
• 229940068965 polysorbates Drugs 0.000 claims description 6
• 239000003755 preservative agent Substances 0.000 claims description 6
• 230000002335 preservative effect Effects 0.000 claims description 6
• 239000008107 starch Substances 0.000 claims description 6
• 235000019698 starch Nutrition 0.000 claims description 6
• 230000001228 trophic effect Effects 0.000 claims description 6
• 239000002753 trypsin inhibitor Substances 0.000 claims description 6
• 230000003612 virological effect Effects 0.000 claims description 6
• KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 5
• KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 claims description 5
• 102400000967 Bradykinin Human genes 0.000 claims description 5
• 101800004538 Bradykinin Proteins 0.000 claims description 5
• 239000004375 Dextrin Substances 0.000 claims description 5
• 229920001353 Dextrin Polymers 0.000 claims description 5
• 102000003951 Erythropoietin Human genes 0.000 claims description 5
• 108090000394 Erythropoietin Proteins 0.000 claims description 5
• 229920002683 Glycosaminoglycan Polymers 0.000 claims description 5
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 5
• QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 claims description 5
• 229920002971 Heparan sulfate Polymers 0.000 claims description 5
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 5
• 102000006947 Histones Human genes 0.000 claims description 5
• 108010033040 Histones Proteins 0.000 claims description 5
• 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 claims description 5
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 claims description 5
• 102000004157 Hydrolases Human genes 0.000 claims description 5
• 108090000604 Hydrolases Proteins 0.000 claims description 5
• 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 5
• 102000004317 Lyases Human genes 0.000 claims description 5
• 108090000856 Lyases Proteins 0.000 claims description 5
• 102000018697 Membrane Proteins Human genes 0.000 claims description 5
• 108010052285 Membrane Proteins Proteins 0.000 claims description 5
• 102000047918 Myelin Basic Human genes 0.000 claims description 5
• 101710107068 Myelin basic protein Proteins 0.000 claims description 5
• SBKRTALNRRAOJP-BWSIXKJUSA-N N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide (6S)-N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide sulfuric acid Polymers OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O SBKRTALNRRAOJP-BWSIXKJUSA-N 0.000 claims description 5
• 108010063734 Oxalate oxidase Proteins 0.000 claims description 5
• 229910019142 PO4 Inorganic materials 0.000 claims description 5
• 102000003982 Parathyroid hormone Human genes 0.000 claims description 5
• 108090000445 Parathyroid hormone Proteins 0.000 claims description 5
• 229920000331 Polyhydroxybutyrate Polymers 0.000 claims description 5
• 108010093965 Polymyxin B Proteins 0.000 claims description 5
• 239000005700 Putrescine Substances 0.000 claims description 5
• 229960005070 ascorbic acid Drugs 0.000 claims description 5
• 239000003114 blood coagulation factor Substances 0.000 claims description 5
• 235000019425 dextrin Nutrition 0.000 claims description 5
• XJWSAJYUBXQQDR-UHFFFAOYSA-M dodecyltrimethylammonium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)C XJWSAJYUBXQQDR-UHFFFAOYSA-M 0.000 claims description 5
• 229940105423 erythropoietin Drugs 0.000 claims description 5
• 230000035558 fertility Effects 0.000 claims description 5
• 235000011187 glycerol Nutrition 0.000 claims description 5
• 229920000669 heparin Polymers 0.000 claims description 5
• 229960002897 heparin Drugs 0.000 claims description 5
• 229920002674 hyaluronan Polymers 0.000 claims description 5
• 229960003160 hyaluronic acid Drugs 0.000 claims description 5
• 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 5
• 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 5
• 229940071676 hydroxypropylcellulose Drugs 0.000 claims description 5
• 239000000199 parathyroid hormone Substances 0.000 claims description 5
• 229960001319 parathyroid hormone Drugs 0.000 claims description 5
• 229960003548 polymyxin b sulfate Drugs 0.000 claims description 5
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims description 5
• 229940063675 spermine Drugs 0.000 claims description 5
• RTQWWZBSTRGEAV-PKHIMPSTSA-N 2-[[(2s)-2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound CNC(=O)NC1=CC=C(C[C@@H](CN(CC(C)N(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 RTQWWZBSTRGEAV-PKHIMPSTSA-N 0.000 claims description 4
• 108010031480 Artificial Receptors Proteins 0.000 claims description 4
• 241000589513 Burkholderia cepacia Species 0.000 claims description 4
• 108010069514 Cyclic Peptides Proteins 0.000 claims description 4
• 102000001189 Cyclic Peptides Human genes 0.000 claims description 4
• 101710088194 Dehydrogenase Proteins 0.000 claims description 4
• 102100036238 Dihydropyrimidinase Human genes 0.000 claims description 4
• 102000012673 Follicle Stimulating Hormone Human genes 0.000 claims description 4
• 108010079345 Follicle Stimulating Hormone Proteins 0.000 claims description 4
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 4
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 4
• 108090000769 Isomerases Proteins 0.000 claims description 4
• 102000004195 Isomerases Human genes 0.000 claims description 4
• 108010029541 Laccase Proteins 0.000 claims description 4
• 108090000364 Ligases Proteins 0.000 claims description 4
• 102000003960 Ligases Human genes 0.000 claims description 4
• WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 4
• 108010033272 Nitrilase Proteins 0.000 claims description 4
• 108700020962 Peroxidase Proteins 0.000 claims description 4
• 102000003992 Peroxidases Human genes 0.000 claims description 4
• 102000004357 Transferases Human genes 0.000 claims description 4
• 108090000992 Transferases Proteins 0.000 claims description 4
• 229960000446 abciximab Drugs 0.000 claims description 4
• 102000030621 adenylate cyclase Human genes 0.000 claims description 4
• 108060000200 adenylate cyclase Proteins 0.000 claims description 4
• 229960004669 basiliximab Drugs 0.000 claims description 4
• QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 claims description 4
• 229960002806 daclizumab Drugs 0.000 claims description 4
• 108091022884 dihydropyrimidinase Proteins 0.000 claims description 4
• 229940028334 follicle stimulating hormone Drugs 0.000 claims description 4
• 229960000578 gemtuzumab Drugs 0.000 claims description 4
• 229960003297 gemtuzumab ozogamicin Drugs 0.000 claims description 4
• 229960001001 ibritumomab tiuxetan Drugs 0.000 claims description 4
• 229960000598 infliximab Drugs 0.000 claims description 4
• 238000007918 intramuscular administration Methods 0.000 claims description 4
• 229960000402 palivizumab Drugs 0.000 claims description 4
• 229920002721 polycyanoacrylate Polymers 0.000 claims description 4
• 229920002704 polyhistidine Polymers 0.000 claims description 4
• 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 4
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 4
• 229940069328 povidone Drugs 0.000 claims description 4
• 240000006439 Aspergillus oryzae Species 0.000 claims description 3
• 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 3
• 102000004877 Insulin Human genes 0.000 claims description 3
• 108090001061 Insulin Proteins 0.000 claims description 3
• 239000011548 crystallization buffer Substances 0.000 claims description 3
• QZTKDVCDBIDYMD-UHFFFAOYSA-N 2,2'-[(2-amino-2-oxoethyl)imino]diacetic acid Chemical compound NC(=O)CN(CC(O)=O)CC(O)=O QZTKDVCDBIDYMD-UHFFFAOYSA-N 0.000 claims description 2
• BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 2
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
• 102000014413 Neuregulin Human genes 0.000 claims description 2
• 108050003475 Neuregulin Proteins 0.000 claims description 2
• OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 claims description 2
• MKKIWWXKPGIMGN-UHFFFAOYSA-N boric acid;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OB(O)O.OC(=O)CC(O)(C(O)=O)CC(O)=O MKKIWWXKPGIMGN-UHFFFAOYSA-N 0.000 claims description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
• 239000010452 phosphate Substances 0.000 claims description 2
• 229940005267 urate oxidase Drugs 0.000 claims description 2
• 150000004676 glycans Chemical class 0.000 claims 3
• 102000014015 Growth Differentiation Factors Human genes 0.000 claims 2
• 108010050777 Growth Differentiation Factors Proteins 0.000 claims 2
• 210000002540 macrophage Anatomy 0.000 claims 1
• 238000004090 dissolution Methods 0.000 description 51
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 33
• 235000002639 sodium chloride Nutrition 0.000 description 29
• 239000011734 sodium Substances 0.000 description 27
• 229910052708 sodium Inorganic materials 0.000 description 26
• 239000006228 supernatant Substances 0.000 description 26
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 25
• 239000001639 calcium acetate Substances 0.000 description 25
• 235000011092 calcium acetate Nutrition 0.000 description 25
• 229960005147 calcium acetate Drugs 0.000 description 25
• 235000015424 sodium Nutrition 0.000 description 25
• VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 24
• 239000007983 Tris buffer Substances 0.000 description 20
• 238000010668 complexation reaction Methods 0.000 description 20
• 229950008679 protamine sulfate Drugs 0.000 description 20
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 20
• 229920001223 polyethylene glycol Polymers 0.000 description 19
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 18
• 238000000399 optical microscopy Methods 0.000 description 18
• 239000000725 suspension Substances 0.000 description 18
• 239000011780 sodium chloride Substances 0.000 description 16
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 15
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
• 239000008188 pellet Substances 0.000 description 15
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 13
• 102000014429 Insulin-like growth factor Human genes 0.000 description 13
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 13
• 238000009472 formulation Methods 0.000 description 13
• 150000003839 salts Chemical class 0.000 description 13
• 210000002966 serum Anatomy 0.000 description 13
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 12
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
• 238000013268 sustained release Methods 0.000 description 12
• 239000012730 sustained-release form Substances 0.000 description 12
• 241001465754 Metazoa Species 0.000 description 10
• 241000700159 Rattus Species 0.000 description 10
• 239000002202 Polyethylene glycol Substances 0.000 description 9
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 9
• 229930006000 Sucrose Natural products 0.000 description 9
• 238000002835 absorbance Methods 0.000 description 9
• 229940024606 amino acid Drugs 0.000 description 9
• 150000001875 compounds Chemical class 0.000 description 9
• 239000012452 mother liquor Substances 0.000 description 9
• 239000001103 potassium chloride Substances 0.000 description 9
• 235000011164 potassium chloride Nutrition 0.000 description 9
• 239000005720 sucrose Substances 0.000 description 9
• 241000282693 Cercopithecidae Species 0.000 description 8
• 235000010355 mannitol Nutrition 0.000 description 8
• 239000001632 sodium acetate Substances 0.000 description 8
• 235000017281 sodium acetate Nutrition 0.000 description 8
• 238000012360 testing method Methods 0.000 description 8
• 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 7
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
• 238000004458 analytical method Methods 0.000 description 7
• 229940073621 enbrel Drugs 0.000 description 7
• 235000019441 ethanol Nutrition 0.000 description 7
• 239000000178 monomer Substances 0.000 description 7
• 102100027723 Endogenous retrovirus group K member 6 Rec protein Human genes 0.000 description 6
• 101710121417 Envelope glycoprotein Proteins 0.000 description 6
• 241000588724 Escherichia coli Species 0.000 description 6
• 239000004471 Glycine Substances 0.000 description 6
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
• DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 6
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 6
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 6
• 239000000654 additive Substances 0.000 description 6
• 230000000996 additive effect Effects 0.000 description 6
• 239000012527 feed solution Substances 0.000 description 6
• 239000003446 ligand Substances 0.000 description 6
• 239000003981 vehicle Substances 0.000 description 6
• 230000004584 weight gain Effects 0.000 description 6
• 235000019786 weight gain Nutrition 0.000 description 6
• 239000004254 Ammonium phosphate Substances 0.000 description 5
• 102000004889 Interleukin-6 Human genes 0.000 description 5
• 102000004890 Interleukin-8 Human genes 0.000 description 5
• 241000288906 Primates Species 0.000 description 5
• 229910000148 ammonium phosphate Inorganic materials 0.000 description 5
• 235000019289 ammonium phosphates Nutrition 0.000 description 5
• 238000005119 centrifugation Methods 0.000 description 5
• 230000001186 cumulative effect Effects 0.000 description 5
• MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 5
• 238000004007 reversed phase HPLC Methods 0.000 description 5
• 239000007787 solid Substances 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 229960000187 tissue plasminogen activator Drugs 0.000 description 5
• HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 4
• SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 4
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 4
• 239000004366 Glucose oxidase Substances 0.000 description 4
• 108010015776 Glucose oxidase Proteins 0.000 description 4
• 239000007987 MES buffer Substances 0.000 description 4
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
• 241000700157 Rattus norvegicus Species 0.000 description 4
• HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 4
• 230000002378 acidificating effect Effects 0.000 description 4
• 239000002671 adjuvant Substances 0.000 description 4
• HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 4
• 238000013461 design Methods 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 4
• 229940116332 glucose oxidase Drugs 0.000 description 4
• 235000019420 glucose oxidase Nutrition 0.000 description 4
• 229910052739 hydrogen Inorganic materials 0.000 description 4
• 230000001965 increasing effect Effects 0.000 description 4
• 238000011534 incubation Methods 0.000 description 4
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
• 230000000366 juvenile effect Effects 0.000 description 4
• 235000021317 phosphate Nutrition 0.000 description 4
• 230000008569 process Effects 0.000 description 4
• 238000003998 size exclusion chromatography high performance liquid chromatography Methods 0.000 description 4
• 239000001509 sodium citrate Substances 0.000 description 4
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
• 239000002904 solvent Substances 0.000 description 4
• 239000011550 stock solution Substances 0.000 description 4
• 238000011282 treatment Methods 0.000 description 4
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
• 239000004475 Arginine Substances 0.000 description 3
• 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 3
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 3
• 102100022641 Coagulation factor IX Human genes 0.000 description 3
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
• 108010076282 Factor IX Proteins 0.000 description 3
• 102100025390 Integrin beta-2 Human genes 0.000 description 3
• 108010002352 Interleukin-1 Proteins 0.000 description 3
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
• 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
• 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 3
• 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 3
• 102100040247 Tumor necrosis factor Human genes 0.000 description 3
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
• 235000009697 arginine Nutrition 0.000 description 3
• 239000011575 calcium Substances 0.000 description 3
• 150000001720 carbohydrates Chemical group 0.000 description 3
• 230000001143 conditioned effect Effects 0.000 description 3
• 229920001577 copolymer Polymers 0.000 description 3
• 238000011033 desalting Methods 0.000 description 3
• 229940061607 dibasic sodium phosphate Drugs 0.000 description 3
• 238000010828 elution Methods 0.000 description 3
• 229960004222 factor ix Drugs 0.000 description 3
• 230000005484 gravity Effects 0.000 description 3
• 238000004128 high performance liquid chromatography Methods 0.000 description 3
• 238000001727 in vivo Methods 0.000 description 3
• 238000011068 loading method Methods 0.000 description 3
• 229920002521 macromolecule Polymers 0.000 description 3
• 239000000463 material Substances 0.000 description 3
• 239000004005 microsphere Substances 0.000 description 3
• 230000007935 neutral effect Effects 0.000 description 3
• 244000045947 parasite Species 0.000 description 3
• 239000008194 pharmaceutical composition Substances 0.000 description 3
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 3
• 108010055896 polyornithine Proteins 0.000 description 3
• 229920002714 polyornithine Polymers 0.000 description 3
• 150000004804 polysaccharides Chemical class 0.000 description 3
• 238000002360 preparation method Methods 0.000 description 3
• 102000005962 receptors Human genes 0.000 description 3
• 108020003175 receptors Proteins 0.000 description 3
• 238000005406 washing Methods 0.000 description 3
• JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical class CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
• 229920000858 Cyclodextrin Polymers 0.000 description 2
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
• SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
• IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
• 102000004862 Gastrin releasing peptide Human genes 0.000 description 2
• 108090001053 Gastrin releasing peptide Proteins 0.000 description 2
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
• 108090000176 Interleukin-13 Proteins 0.000 description 2
• 102000000743 Interleukin-5 Human genes 0.000 description 2
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 2
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
• 239000004472 Lysine Substances 0.000 description 2
• 102000015728 Mucins Human genes 0.000 description 2
• 108010063954 Mucins Proteins 0.000 description 2
• 206010028980 Neoplasm Diseases 0.000 description 2
• 102000004264 Osteopontin Human genes 0.000 description 2
• 108010081689 Osteopontin Proteins 0.000 description 2
• 229920002582 Polyethylene Glycol 600 Polymers 0.000 description 2
• 239000004372 Polyvinyl alcohol Substances 0.000 description 2
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
• 108010072866 Prostate-Specific Antigen Proteins 0.000 description 2
• 102100038358 Prostate-specific antigen Human genes 0.000 description 2
• PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 2
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 150000001298 alcohols Chemical class 0.000 description 2
• 230000001668 ameliorated effect Effects 0.000 description 2
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
• 235000003704 aspartic acid Nutrition 0.000 description 2
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 229910052791 calcium Inorganic materials 0.000 description 2
• 239000001110 calcium chloride Substances 0.000 description 2
• 229910001628 calcium chloride Inorganic materials 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
• 239000002131 composite material Substances 0.000 description 2
• 238000013270 controlled release Methods 0.000 description 2
• 239000011549 crystallization solution Substances 0.000 description 2
• 150000002016 disaccharides Chemical class 0.000 description 2
• 238000007922 dissolution test Methods 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 230000002349 favourable effect Effects 0.000 description 2
• 239000000945 filler Substances 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• PUBCCFNQJQKCNC-XKNFJVFFSA-N gastrin-releasingpeptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C1=CNC=N1 PUBCCFNQJQKCNC-XKNFJVFFSA-N 0.000 description 2
• 239000000499 gel Substances 0.000 description 2
• 102000034238 globular proteins Human genes 0.000 description 2
• 108091005896 globular proteins Proteins 0.000 description 2
• 235000013922 glutamic acid Nutrition 0.000 description 2
• 239000004220 glutamic acid Substances 0.000 description 2
• 229920000140 heteropolymer Polymers 0.000 description 2
• 229940051250 hexylene glycol Drugs 0.000 description 2
• 229960002885 histidine Drugs 0.000 description 2
• 229920001519 homopolymer Polymers 0.000 description 2
• 125000001841 imino group Chemical group [H]N=* 0.000 description 2
• 239000004615 ingredient Substances 0.000 description 2
• 229940125396 insulin Drugs 0.000 description 2
• 239000000832 lactitol Substances 0.000 description 2
• VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 2
• 235000010448 lactitol Nutrition 0.000 description 2
• 229960003451 lactitol Drugs 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 239000000787 lecithin Chemical class 0.000 description 2
• 235000010445 lecithin Nutrition 0.000 description 2
• 229940067606 lecithin Drugs 0.000 description 2
• 239000007788 liquid Substances 0.000 description 2
• 235000018977 lysine Nutrition 0.000 description 2
• 229910001629 magnesium chloride Inorganic materials 0.000 description 2
• 238000005259 measurement Methods 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• ODLHGICHYURWBS-FOSILIAISA-N molport-023-220-444 Chemical compound CC(O)COC[C@@H]([C@@H]([C@H]([C@@H]1O)O)O[C@@H]2O[C@H]([C@H](O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O3)[C@@H](O)[C@@H]2O)COCC(O)C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@H]3O[C@H]1COCC(C)O ODLHGICHYURWBS-FOSILIAISA-N 0.000 description 2
• 150000002772 monosaccharides Chemical class 0.000 description 2
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical class CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
• 239000003960 organic solvent Substances 0.000 description 2
• 230000003204 osmotic effect Effects 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 239000007981 phosphate-citrate buffer Substances 0.000 description 2
• 230000000704 physical effect Effects 0.000 description 2
• 229920000867 polyelectrolyte Polymers 0.000 description 2
• 229920002451 polyvinyl alcohol Polymers 0.000 description 2
• 239000013641 positive control Substances 0.000 description 2
• 239000011591 potassium Substances 0.000 description 2
• 235000007686 potassium Nutrition 0.000 description 2
• 229910052700 potassium Inorganic materials 0.000 description 2
• 239000002244 precipitate Substances 0.000 description 2
• 230000000069 prophylactic effect Effects 0.000 description 2
• 229960001790 sodium citrate Drugs 0.000 description 2
• 239000000600 sorbitol Substances 0.000 description 2
• 235000010356 sorbitol Nutrition 0.000 description 2
• 230000004936 stimulating effect Effects 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 2
• 238000003260 vortexing Methods 0.000 description 2
• QZNNVYOVQUKYSC-JEDNCBNOSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydron;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CN=CN1 QZNNVYOVQUKYSC-JEDNCBNOSA-N 0.000 description 1
• LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 1
• ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical class CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Chemical class CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
• RMTXUPIIESNLPW-UHFFFAOYSA-N 1,2-dihydroxy-3-(pentadeca-8,11-dienyl)benzene Natural products CCCC=CCC=CCCCCCCCC1=CC=CC(O)=C1O RMTXUPIIESNLPW-UHFFFAOYSA-N 0.000 description 1
• OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
• CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical class NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Chemical class CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
• 108050001326 26S Proteasome regulatory subunit 6A Proteins 0.000 description 1
• 102100029510 26S proteasome regulatory subunit 6A Human genes 0.000 description 1
• QARRXYBJLBIVAK-UEMSJJPVSA-N 3-[(8e,11e)-pentadeca-8,11-dienyl]benzene-1,2-diol;3-[(8e,11e)-pentadeca-8,11,14-trienyl]benzene-1,2-diol;3-[(8e,11e,13e)-pentadeca-8,11,13-trienyl]benzene-1,2-diol;3-[(e)-pentadec-8-enyl]benzene-1,2-diol;3-pentadecylbenzene-1,2-diol Chemical compound CCCCCCCCCCCCCCCC1=CC=CC(O)=C1O.CCCCCC\C=C\CCCCCCCC1=CC=CC(O)=C1O.CCC\C=C\C\C=C\CCCCCCCC1=CC=CC(O)=C1O.C\C=C\C=C\C\C=C\CCCCCCCC1=CC=CC(O)=C1O.OC1=CC=CC(CCCCCCC\C=C\C\C=C\CC=C)=C1O QARRXYBJLBIVAK-UEMSJJPVSA-N 0.000 description 1
• IYROWZYPEIMDDN-UHFFFAOYSA-N 3-n-pentadec-8,11,13-trienyl catechol Natural products CC=CC=CCC=CCCCCCCCC1=CC=CC(O)=C1O IYROWZYPEIMDDN-UHFFFAOYSA-N 0.000 description 1
• INZOTETZQBPBCE-NYLDSJSYSA-N 3-sialyl lewis Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@H](O)CO)[C@@H]([C@@H](NC(C)=O)C=O)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 INZOTETZQBPBCE-NYLDSJSYSA-N 0.000 description 1
• 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
• XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical class CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Chemical class CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
• 101800000263 Acidic protein Proteins 0.000 description 1
• 102100036664 Adenosine deaminase Human genes 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 102100022749 Aminopeptidase N Human genes 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
• 101710081722 Antitrypsin Proteins 0.000 description 1
• 108010039627 Aprotinin Proteins 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 102100025218 B-cell differentiation antigen CD72 Human genes 0.000 description 1
• 102100038080 B-cell receptor CD22 Human genes 0.000 description 1
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
• 108010077805 Bacterial Proteins Proteins 0.000 description 1
• BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 1
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
• 102100027207 CD27 antigen Human genes 0.000 description 1
• 101150013553 CD40 gene Proteins 0.000 description 1
• 102100032937 CD40 ligand Human genes 0.000 description 1
• 102100032912 CD44 antigen Human genes 0.000 description 1
• 108010084313 CD58 Antigens Proteins 0.000 description 1
• 108010021064 CTLA-4 Antigen Proteins 0.000 description 1
• 229940045513 CTLA4 antagonist Drugs 0.000 description 1
• 101100289995 Caenorhabditis elegans mac-1 gene Proteins 0.000 description 1
• 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 description 1
• 244000025254 Cannabis sativa Species 0.000 description 1
• 108010055166 Chemokine CCL5 Proteins 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 206010053567 Coagulopathies Diseases 0.000 description 1
• 108010078015 Complement C3b Proteins 0.000 description 1
• 108010078546 Complement C5a Proteins 0.000 description 1
• 102100030886 Complement receptor type 1 Human genes 0.000 description 1
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 1
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
• LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
• 101100120663 Drosophila melanogaster fs(1)h gene Proteins 0.000 description 1
• 102100038083 Endosialin Human genes 0.000 description 1
• 101710144543 Endosialin Proteins 0.000 description 1
• 102000002045 Endothelin Human genes 0.000 description 1
• 108050009340 Endothelin Proteins 0.000 description 1
• 102100036509 Erythropoietin receptor Human genes 0.000 description 1
• 101710102442 Erythropoietin receptor Proteins 0.000 description 1
• 101000703368 Escherichia coli (strain K12) L-asparaginase 2 Proteins 0.000 description 1
• 101000759376 Escherichia phage Mu Tail sheath protein Proteins 0.000 description 1
• 108091008794 FGF receptors Proteins 0.000 description 1
• 102000009123 Fibrin Human genes 0.000 description 1
• 108010073385 Fibrin Proteins 0.000 description 1
• BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
• 108010049003 Fibrinogen Proteins 0.000 description 1
• 102000008946 Fibrinogen Human genes 0.000 description 1
• 108010090109 Fibrolase Proteins 0.000 description 1
• 229930091371 Fructose Natural products 0.000 description 1
• RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
• 239000005715 Fructose Substances 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 229920002527 Glycogen Polymers 0.000 description 1
• 108010009202 Growth Factor Receptors Proteins 0.000 description 1
• 102000009465 Growth Factor Receptors Human genes 0.000 description 1
• 229920002907 Guar gum Polymers 0.000 description 1
• SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
• 102000030789 Histidine Ammonia-Lyase Human genes 0.000 description 1
• 108700006308 Histidine ammonia-lyases Proteins 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 description 1
• 101000934359 Homo sapiens B-cell differentiation antigen CD72 Proteins 0.000 description 1
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 1
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
• 101000868215 Homo sapiens CD40 ligand Proteins 0.000 description 1
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
• 101000727061 Homo sapiens Complement receptor type 1 Proteins 0.000 description 1
• 101000987586 Homo sapiens Eosinophil peroxidase Proteins 0.000 description 1
• 101000920686 Homo sapiens Erythropoietin Proteins 0.000 description 1
• 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
• 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
• 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 description 1
• 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 1
• 101001063392 Homo sapiens Lymphocyte function-associated antigen 3 Proteins 0.000 description 1
• 101000899339 Homo sapiens Lymphoid-specific helicase Proteins 0.000 description 1
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 1
• 101000995705 Homo sapiens Natural resistance-associated macrophage protein 1 Proteins 0.000 description 1
• 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 1
• 101000973997 Homo sapiens Nucleosome assembly protein 1-like 4 Proteins 0.000 description 1
• 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 description 1
• 101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 description 1
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 1
• 101000772267 Homo sapiens Thyrotropin receptor Proteins 0.000 description 1
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
• 101150088952 IGF1 gene Proteins 0.000 description 1
• 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
• 102100025323 Integrin alpha-1 Human genes 0.000 description 1
• 102100032817 Integrin alpha-5 Human genes 0.000 description 1
• 102100032816 Integrin alpha-6 Human genes 0.000 description 1
• 108010041341 Integrin alpha1 Proteins 0.000 description 1
• 108010055795 Integrin alpha1beta1 Proteins 0.000 description 1
• 108010017642 Integrin alpha2beta1 Proteins 0.000 description 1
• 108010008212 Integrin alpha4beta1 Proteins 0.000 description 1
• 108010041014 Integrin alpha5 Proteins 0.000 description 1
• 108010042918 Integrin alpha5beta1 Proteins 0.000 description 1
• 108010041100 Integrin alpha6 Proteins 0.000 description 1
• 108010030465 Integrin alpha6beta1 Proteins 0.000 description 1
• 102100025304 Integrin beta-1 Human genes 0.000 description 1
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 102100037872 Intercellular adhesion molecule 2 Human genes 0.000 description 1
• 101710148794 Intercellular adhesion molecule 2 Proteins 0.000 description 1
• 102000001617 Interferon Receptors Human genes 0.000 description 1
• 108010054267 Interferon Receptors Proteins 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 108090000177 Interleukin-11 Proteins 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 102100020793 Interleukin-13 receptor subunit alpha-2 Human genes 0.000 description 1
• 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 1
• 102000015696 Interleukins Human genes 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
• 108010092694 L-Selectin Proteins 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• 102100033467 L-selectin Human genes 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• 101000844802 Lacticaseibacillus rhamnosus Teichoic acid D-alanyltransferase Proteins 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
• 102100030984 Lymphocyte function-associated antigen 3 Human genes 0.000 description 1
• 102100022539 Lymphoid-specific helicase Human genes 0.000 description 1
• 102000043129 MHC class I family Human genes 0.000 description 1
• 108091054437 MHC class I family Proteins 0.000 description 1
• 102000043131 MHC class II family Human genes 0.000 description 1
• 108091054438 MHC class II family Proteins 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 101710091439 Major capsid protein 1 Proteins 0.000 description 1
• 229920002774 Maltodextrin Polymers 0.000 description 1
• GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 1
• 102000006386 Myelin Proteins Human genes 0.000 description 1
• 108010083674 Myelin Proteins Proteins 0.000 description 1
• 108010025020 Nerve Growth Factor Proteins 0.000 description 1
• 102000007072 Nerve Growth Factors Human genes 0.000 description 1
• 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 1
• 102400000503 Neutrophil-activating peptide 2 Human genes 0.000 description 1
• 239000005642 Oleic acid Chemical class 0.000 description 1
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Chemical class CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
• 108010035766 P-Selectin Proteins 0.000 description 1
• 102100023472 P-selectin Human genes 0.000 description 1
• 239000008118 PEG 6000 Substances 0.000 description 1
• 108700020797 Parathyroid Hormone-Related Proteins 0.000 description 1
• 102000043299 Parathyroid hormone-related Human genes 0.000 description 1
• 102000013566 Plasminogen Human genes 0.000 description 1
• 108010051456 Plasminogen Proteins 0.000 description 1
• 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 description 1
• RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical class C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
• 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
• 229920002675 Polyoxyl Chemical class 0.000 description 1
• 229920001213 Polysorbate 20 Polymers 0.000 description 1
• 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
• 101000703403 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) L-asparaginase 2-1 Proteins 0.000 description 1
• 101000703404 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) L-asparaginase 2-2 Proteins 0.000 description 1
• 101000901050 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) L-asparaginase 2-3 Proteins 0.000 description 1
• 101000901051 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) L-asparaginase 2-4 Proteins 0.000 description 1
• 241000711981 Sais Species 0.000 description 1
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical class [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
• HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical class CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• 241000201776 Steno Species 0.000 description 1
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 1
• 101710136628 TATA element modulatory factor Proteins 0.000 description 1
• 102100029337 Thyrotropin receptor Human genes 0.000 description 1
• 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
• 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
• 108091008605 VEGF receptors Proteins 0.000 description 1
• 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 1
• 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 1
• 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 1
• 108010087302 Viral Structural Proteins Proteins 0.000 description 1
• 238000002441 X-ray diffraction Methods 0.000 description 1
• TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• 150000001242 acetic acid derivatives Chemical class 0.000 description 1
• JCFADYTWTKDWKU-UHFFFAOYSA-N acetic acid;hydrochloride Chemical compound Cl.CC(O)=O.CC(O)=O JCFADYTWTKDWKU-UHFFFAOYSA-N 0.000 description 1
• WJGAPUXHSQQWQF-UHFFFAOYSA-N acetic acid;hydrochloride Chemical compound Cl.CC(O)=O WJGAPUXHSQQWQF-UHFFFAOYSA-N 0.000 description 1
• PZAGQUOSOTUKEC-UHFFFAOYSA-N acetic acid;sulfuric acid Chemical compound CC(O)=O.OS(O)(=O)=O PZAGQUOSOTUKEC-UHFFFAOYSA-N 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 238000012382 advanced drug delivery Methods 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
• IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 239000000783 alginic acid Substances 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 229960001126 alginic acid Drugs 0.000 description 1
• 150000004781 alginic acids Chemical class 0.000 description 1
• 108010060162 alglucerase Proteins 0.000 description 1
• 239000013566 allergen Substances 0.000 description 1
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
• WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
• 229960003318 alteplase Drugs 0.000 description 1
• PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
• CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
• 229940063655 aluminum stearate Drugs 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• 239000001099 ammonium carbonate Substances 0.000 description 1
• 235000012501 ammonium carbonate Nutrition 0.000 description 1
• 229940010556 ammonium phosphate Drugs 0.000 description 1
• 238000012801 analytical assay Methods 0.000 description 1
• 230000001475 anti-trypsic effect Effects 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 229960004405 aprotinin Drugs 0.000 description 1
• 239000003125 aqueous solvent Substances 0.000 description 1
• PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
• 229940072107 ascorbate Drugs 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 210000001142 back Anatomy 0.000 description 1
• 239000003659 bee venom Substances 0.000 description 1
• GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
• 230000000975 bioactive effect Effects 0.000 description 1
• 229920002988 biodegradable polymer Polymers 0.000 description 1
• 239000004621 biodegradable polymer Substances 0.000 description 1
• 229920001400 block copolymer Polymers 0.000 description 1
• 230000023555 blood coagulation Effects 0.000 description 1
• 229960000182 blood factors Drugs 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
• 239000004327 boric acid Substances 0.000 description 1
• 235000010338 boric acid Nutrition 0.000 description 1
• 230000003139 buffering effect Effects 0.000 description 1
• 229960002713 calcium chloride Drugs 0.000 description 1
• 229940112129 campath Drugs 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 150000001860 citric acid derivatives Chemical class 0.000 description 1
• 230000035602 clotting Effects 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 239000008119 colloidal silica Substances 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 230000000536 complexating effect Effects 0.000 description 1
• 239000000470 constituent Substances 0.000 description 1
• 229940097362 cyclodextrins Drugs 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
• 229940043237 diethanolamine Drugs 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 238000002651 drug therapy Methods 0.000 description 1
• 239000000428 dust Substances 0.000 description 1
• 230000002500 effect on skin Effects 0.000 description 1
• 230000000694 effects Effects 0.000 description 1
• 239000003792 electrolyte Substances 0.000 description 1
• 230000009881 electrostatic interaction Effects 0.000 description 1
• 230000001804 emulsifying effect Effects 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
• 239000002158 endotoxin Substances 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
• BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 238000013401 experimental design Methods 0.000 description 1
• 238000013265 extended release Methods 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 229950003499 fibrin Drugs 0.000 description 1
• 229940012952 fibrinogen Drugs 0.000 description 1
• 102000052178 fibroblast growth factor receptor activity proteins Human genes 0.000 description 1
• 238000005187 foaming Methods 0.000 description 1
• 229930182830 galactose Natural products 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 229940097043 glucuronic acid Drugs 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 235000004554 glutamine Nutrition 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• 229940075507 glyceryl monostearate Drugs 0.000 description 1
• 229960002449 glycine Drugs 0.000 description 1
• 229940096919 glycogen Drugs 0.000 description 1
• 239000003966 growth inhibitor Substances 0.000 description 1
• 239000000665 guar gum Substances 0.000 description 1
• 235000010417 guar gum Nutrition 0.000 description 1
• 229960002154 guar gum Drugs 0.000 description 1
• 230000003394 haemopoietic effect Effects 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 229940022353 herceptin Drugs 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 102000044890 human EPO Human genes 0.000 description 1
• 239000000017 hydrogel Substances 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
• CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
• 229960000367 inositol Drugs 0.000 description 1
• 102000002467 interleukin receptors Human genes 0.000 description 1
• 108010093036 interleukin receptors Proteins 0.000 description 1
• 108040006732 interleukin-1 receptor activity proteins Proteins 0.000 description 1
• 102000014909 interleukin-1 receptor activity proteins Human genes 0.000 description 1
• 108040006870 interleukin-10 receptor activity proteins Proteins 0.000 description 1
• 108040006873 interleukin-11 receptor activity proteins Proteins 0.000 description 1
• 108040003607 interleukin-13 receptor activity proteins Proteins 0.000 description 1
• 108040002039 interleukin-15 receptor activity proteins Proteins 0.000 description 1
• 102000008616 interleukin-15 receptor activity proteins Human genes 0.000 description 1
• 108040006849 interleukin-2 receptor activity proteins Proteins 0.000 description 1
• 108040006852 interleukin-4 receptor activity proteins Proteins 0.000 description 1
• 108040006859 interleukin-5 receptor activity proteins Proteins 0.000 description 1
• 108040006858 interleukin-6 receptor activity proteins Proteins 0.000 description 1
• 108040006861 interleukin-7 receptor activity proteins Proteins 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 238000001361 intraarterial administration Methods 0.000 description 1
• 238000007917 intracranial administration Methods 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 238000005342 ion exchange Methods 0.000 description 1
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Chemical class CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
• 239000000644 isotonic solution Substances 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 235000011147 magnesium chloride Nutrition 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 229960001855 mannitol Drugs 0.000 description 1
• HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
• 238000000386 microscopy Methods 0.000 description 1
• 239000001788 mono and diglycerides of fatty acids Chemical class 0.000 description 1
• 229940051875 mucins Drugs 0.000 description 1
• 210000005012 myelin Anatomy 0.000 description 1
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
• 108020004707 nucleic acids Proteins 0.000 description 1
• 102000039446 nucleic acids Human genes 0.000 description 1
• 150000007523 nucleic acids Chemical class 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• 229960002969 oleic acid Drugs 0.000 description 1
• 229940055577 oleyl alcohol Drugs 0.000 description 1
• XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Chemical class CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
• 238000000879 optical micrograph Methods 0.000 description 1
• 229940029358 orthoclone okt3 Drugs 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 229920001277 pectin Polymers 0.000 description 1
• 239000001814 pectin Substances 0.000 description 1
• 235000010987 pectin Nutrition 0.000 description 1
• 108700037519 pegvisomant Proteins 0.000 description 1
• 229960002995 pegvisomant Drugs 0.000 description 1
• 229940021222 peritoneal dialysis isotonic solution Drugs 0.000 description 1
• 230000003285 pharmacodynamic effect Effects 0.000 description 1
• 229960000502 poloxamer Drugs 0.000 description 1
• 229920001308 poly(aminoacid) Polymers 0.000 description 1
• 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
• 229920002643 polyglutamic acid Polymers 0.000 description 1
• 238000006116 polymerization reaction Methods 0.000 description 1
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
• 229950008882 polysorbate Drugs 0.000 description 1
• 229940068977 polysorbate 20 Drugs 0.000 description 1
• 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
• 239000004302 potassium sorbate Substances 0.000 description 1
• 235000010241 potassium sorbate Nutrition 0.000 description 1
• 229940069338 potassium sorbate Drugs 0.000 description 1
• 238000000634 powder X-ray diffraction Methods 0.000 description 1
• 235000013930 proline Nutrition 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 239000008213 purified water Substances 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 210000003752 saphenous vein Anatomy 0.000 description 1
• 229920006395 saturated elastomer Polymers 0.000 description 1
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• 238000001542 size-exclusion chromatography Methods 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 239000003998 snake venom Substances 0.000 description 1
• 239000007974 sodium acetate buffer Substances 0.000 description 1
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 230000003381 solubilizing effect Effects 0.000 description 1
• 235000010199 sorbic acid Nutrition 0.000 description 1
• 239000004334 sorbic acid Substances 0.000 description 1
• 229940075582 sorbic acid Drugs 0.000 description 1
• 229940035044 sorbitan monolaurate Drugs 0.000 description 1
• 239000001587 sorbitan monostearate Chemical class 0.000 description 1
• 235000011076 sorbitan monostearate Nutrition 0.000 description 1
• 229940035048 sorbitan monostearate Drugs 0.000 description 1
• 229960002920 sorbitol Drugs 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 229910001220 stainless steel Inorganic materials 0.000 description 1
• 239000010935 stainless steel Substances 0.000 description 1
• 239000008117 stearic acid Chemical class 0.000 description 1
• 229960004274 stearic acid Drugs 0.000 description 1
• 238000003756 stirring Methods 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 150000005846 sugar alcohols Chemical class 0.000 description 1
• 229960000814 tetanus toxoid Drugs 0.000 description 1
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
• 210000001519 tissue Anatomy 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1
• 239000013638 trimer Substances 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• MDYZKJNTKZIUSK-UHFFFAOYSA-N tyloxapol Chemical compound O=C.C1CO1.CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1 MDYZKJNTKZIUSK-UHFFFAOYSA-N 0.000 description 1
• 229920001664 tyloxapol Polymers 0.000 description 1
• 229960004224 tyloxapol Drugs 0.000 description 1
• 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
• 241000712461 unidentified influenza virus Species 0.000 description 1
• DQTMTQZSOJMZSF-UHFFFAOYSA-N urushiol Natural products CCCCCCCCCCCCCCCC1=CC=CC(O)=C1O DQTMTQZSOJMZSF-UHFFFAOYSA-N 0.000 description 1
• 235000013311 vegetables Nutrition 0.000 description 1
• 239000003643 water by type Substances 0.000 description 1
• 230000003442 weekly effect Effects 0.000 description 1
• 238000005303 weighing Methods 0.000 description 1
• 239000002023 wood Substances 0.000 description 1
• 239000000811 xylitol Substances 0.000 description 1
• HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
• 235000010447 xylitol Nutrition 0.000 description 1
• 229960002675 xylitol Drugs 0.000 description 1
• 150000003751 zinc Chemical class 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1